Cutler Group LP Regeneron Pharmaceuticals, Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$573.97 - $724.32 $303,056 - $382,440	528 Added 306.98%	700 $482,000
Q2 2022 Aug 04, 2022	SELL	$548.35 - $738.84 $987,030 - $1.33 Million	-1,800 Reduced 91.28%	172 $101,000
Q1 2022 Apr 14, 2022	BUY	$595.12 - $698.43 $1.17 Million - $1.38 Million	1,972 New	1,972 $1.38 Million
Q1 2020 May 07, 2020	SELL	$336.18 - $494.43 $38,996 - $57,353	-116 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $1.47 Million - $2.02 Million	-5,368 Reduced 97.88%	116 $43,000
Q4 2017 Jan 17, 2018	BUY	$358.63 - $469.95 $314,518 - $412,146	877 Added 19.04%	5,484 $2.06 Million
Q3 2017 Oct 17, 2017	BUY	$431.38 - $504.0 $1.99 Million - $2.32 Million	4,607	4,607 $2.06 Million

1,489

85.6M

1.54M

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.